Medical device manufacturer Gerresheimer to expand facility and create 200 new jobs

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Drug delivery systems Drug delivery technology Medical devices Gerresheimer Manufacturing Supply chain

Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, Georgia.

The expansion will create more than 200 new jobs adding to the 260 it already supports there.

The German-based company with a plant in Georgia offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems, medical devices, and solutions for the health and cosmetics industry.

The existing Gerresheimer manufacturing facility is already in the midst of an expansion, where it will support an additional 180 jobs with operations beginning in April this year (2024). Today's announcement marks yet another investment by the company here in the No. 1 state for business.

“We appreciate the continuous support of the State of Georgia for our expansion in the US,” said Dietmar Siemssen, CEO of Gerresheimer AG.

“The US market is an important growth driver for us, and expanding our operations in Peachtree City will be key for growing our medical device business in the US We are glad that we have found such favorable conditions and a highly motivated and skilled staff here.”

The state is a hub for life sciences companies because of its strategic location, workforce and flourishing life science company sector, the company said. The life science industry has seen a 20% growth rate in employment since 2015 and supports more than 78,000 jobs and over 4,000 life science organizations throughout the state. In 2022, Georgia exported over $1 billion in medical instruments to international markets.

Gerresheimer’s new facility will be located in the Southpark International Industrial Park in Peachtree City, producing medical devices, particularly autoinjectors, to administer injectable drugs. Operations are expected to begin in the fall.

“This project is a prime example of the exciting growth of the life sciences industry in our state, with companies like Gerresheimer bringing career opportunities to all four corners of Georgia” said Governor Brian Kemp.

“Employers from across the globe can find a skilled workforce here that we are continuously investing in through innovative programs like the GEORGIA MATCH Direct College Admissions Initiative. We're excited to see how this expansion will further benefit the community and surrounding region.”

Peachtree City Mayor Kim Learnard said there was dedication to fostering strong partnerships and economic growth in the city evidenced by support for Gerresheimer’s plans to expand its facility there.

She said: “Gerresheimer's commitment to innovation in the pharmaceutical packaging industry aligns perfectly with our vision for a prosperous and vibrant city. We are excited about the additional employment opportunities and the positive impact this expansion will have on our community.”

Georgia is outpacing the nation in life sciences employment, with a 20 percent growth rate since 2015. The industry supports more than 78,000 jobs statewide, and at least 4,000 life science organizations operate in Georgia. In 2022, Georgia exported over $1 billion in medical instruments to international markets.

Gerresheimer is an inventive system and solution provider and a global partner for the pharma, biotech, and cosmetic industries. The company offers a portfolio of pharmaceutical containment solutions, drug delivery systems, and medical devices as well as solutions for the health and cosmetics industry.

The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors, and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles, and more. 

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Related suppliers